Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial

NCT00255606 is registered in ClinicalTrials.gov with Tampere University as lead sponsor.

NCT NCT00255606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00255606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Trial Comparing Docetaxel Every Third Week to Biweekly Docetaxel Monotherapy in Metastatic Hormone Refractory Prostate Cancer Patients - PROSTY Trial
Lead sponsor
Tampere University
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2005
Completion date
August 31, 2010
Enrollment
360 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer